previous compound ID: 767 next compound
InChIKey: GTVPOLSIJWJJNY-UHFFFAOYSA-N
SMILES: CN1C=NC2=C1N=C(N=C2NCC3=CC=CC=C3)NCCO

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "GW Carlile" "J Liao" "SD Macknight" "DY Thomas" "E Matthes" "D Rotin" "J Goepp" "JW Hanrahan" "R Robert"

chemical graph of compound 767





CID is 4592
synonyms found at PubChem are:
olomoucine, 101622-51-9, 4erk, UNII-6A839B2HYS, InSolution™ Olomoucine, 2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine, 6A839B2HYS, CHEMBL280074, IN1179, 6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine, 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine, 2-{[6-(benzylamino)-9-methyl-9h-purin-2-yl]amino}ethanol, Ethanol,2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, 2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine, OLO, 6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine, 6-benzylamino-2-[2-hydroxyethylamino]-9-methylpurine, 2-(2-Hydroxyethylamino)-6-benzylamino-9-isopropylpurine, 2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol, C15H18N6O, 2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol, SR-01000075518, Olomucine, purine deriv. 5, NSC 666096, NSC-666096, Kinome_2870, Tocris-1284, 1w0x, ACMC-20cp0o, AC1L1IID, AC1Q4XZU, BiomolKI_000046, Lopac-O-0886, BiomolKI2_000052, D00BPA, UPCMLD-DP136, CBiol_002050, Lopac0_000883, BSPBio_000990, KBioGR_000330, KBioSS_000330, SCHEMBL135056, BDBM5718, BMK1-E10, 2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine, Olomoucine, >=98% (HPLC), UPCMLD-DP136:001, UPCMLD-DP136:002, BCBcMAP01_000205, CTK4A0020, KBio2_000330, KBio2_002898, KBio2_005466, KBio3_000659, KBio3_000660, BIO3107, DTXSID90144068, GTVPOLSIJWJJNY-UHFFFAOYSA-N, MolPort-003-849-700, ZX-AFC001655, Bio1_000336, Bio1_000825, Bio1_001314, Bio2_000335, Bio2_000815, HMS1362B11, HMS1792B11, HMS1990B11, HMS3262B08, HMS3267L09, HMS3403B11, HMS3650F19, ZINC1641925, Tox21_500883, 1966AH, IN1182, MFCD00189360, NSC666096, AKOS005145988, CCG-100650, DB02116, LP00883, TRA0035611, IDI1_002090, SMP1_000281, 2,6,9-Trisubstituted purine deriv. 26, NCGC00015763-01, NCGC00015763-02, NCGC00015763-03, NCGC00015763-04, NCGC00015763-05, NCGC00015763-06, NCGC00015763-07, NCGC00015763-08, NCGC00015763-09, NCGC00025096-01, NCGC00025096-02, NCGC00025096-03, NCGC00025096-04, NCGC00025096-05, NCGC00025096-06, NCGC00025096-07, NCGC00261568-01, CJ-26517, NCI60_022916, KB-162429, RT-014854, EU-0100883, FT-0642456, ST50298830, O 0886, C-28477, J-000453, SR-01000075518-1, SR-01000075518-3, SR-01000075518-6, BRD-K82731415-001-03-9, BRD-K82731415-001-04-7, 2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol, 2-({9-methyl-6-[benzylamino]purin-2-yl}amino)ethan-1-ol, 2-(6-(benzylamino)-9-methyl-9H-purin-2-ylamino)ethanol, 6-(benzylamino)-2-[(2-hydroxyethyl)amino]-9-methylpurine, 2-[[9-methyl-6-(phenylmethylamino)purin-2-yl]amino]ethanol, 2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-ethanol, 2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]ethanol, 2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]ethanol, 9CI, Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-